Amedisys (AMED) Tops Q1 EPS by 6c

Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.47, $0.06 better than the analyst estimate of $0.41. Revenue for the quarter came in at $370.46 million versus the consensus estimate of $370.3 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Atmos Energy (ATO) PT Lowered to $185 at Argus
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM